Skip to main content
Premium Trial:

Request an Annual Quote

Exosome Diagnostics, German University Receive €1M Grant to Develop Cancer Dx Tests

Premium

Exosome Diagnostics and the department of dermatology at the Ludwig Maximilian University in Munich have been awarded a €1 million ($1.3 million) grant from the German government to develop diagnostic cancer tests based on RNA from plasma-derived exosomes.

Under the grant, from the German Federal Ministry for Education and Research, the researchers plan to develop diagnostic technology to detect tumor-specific mutations in the blood of patients with malignant cancer in order to monitor disease recurrence, aid therapy selection, and possibly improve early tumor detection. The partners plan to couple exosome-based technology with next-generation sequencing and qPCR instrument platforms.

Exosome Diagnostics plans to offer clinical diagnostic tests developed under the project commercially at its laboratories in St. Paul, Minn., and Munich.

Microvesicles, which include exosomes, contain large quantities of tumor-derived mRNA found in biofluids outside of tumor cells. They provide a stable source of RNA in blood, urine, and spinal fluid.

The company has been developing a multiplexed sequencing method for mRNA from blood and urine exosome preparations, which allows for the sensitive detection of rare gene mutations.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.